Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
The protein p53, best known as the "guardian of the genome" for its role in preventing cancer, can affect blood vessels in ...
The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.
A new hypothesis article was published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis: HPV E6 and COVID ...
Researchers have uncovered a mechanism that allows breast cancer to send metastases to the brain, potentially enabling the ...
Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...
Scientists have recently shed some light on exactly why elephants, one of the biggest animals on the planet, paradoxically experience unusually low rates of cancer. The research found these remarkable ...
At the recent American Society of Hematology annual meeting, researchers presented preclinical data examining how transdifferentiation between hematopoietic lineages -- driven by LMO2 expression and ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
The protein p53, best known as the "guardian of the genome" for its role in preventing cancer, can affect blood vessels in ...